Decomplementation with cobra venom factor prolongs survival of xenografted islets in a rat to mouse model

Immunology

Volumn 97, Issue 1, 1999, Pages 173-180

  Oberholzer, J ^a   Yu, D ^a   Triponez, F ^a   Cretin, N ^a   Andereggen, E ^a   Mentha, G ^a   White, D ^b   Buehler, L ^a   Morel, P ^a   Lou, J ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; SNAKE VENOM;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL SURVIVAL; COMPLEMENT INHIBITION; CONTROLLED STUDY; GRAFT SURVIVAL; MALE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RAT; SURVIVAL TIME; XENOTRANSPLANTATION;

ANIMALS; COBRA VENOMS; COMPLEMENT C3; COMPLEMENT INACTIVATOR PROTEINS; COMPLEMENT SYSTEM PROTEINS; CYTOTOXICITY, IMMUNOLOGIC; GRAFT SURVIVAL; IMMUNOGLOBULIN M; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, INBRED C57BL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032912194     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00742.x     Document Type: Article

References (24)

1. 1. Alejandro R., Lehmann R., Ricordi C. et al. (1997) Long-term function (6 years) of islet allografts in type 1 diabetes. Diabetes 46, 1983.
2. 2. Keymeulen B., Ling Z., Gorus F. et al. (1998) Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipient characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft. Diabetologia 41, 452.
3. 3. Thomas F. (1997) Isolated pancreatic islet xenografting. In: Xenotransplantation (eds D. Cooper, E. Kemp, J. Platt & D. White), p. 545. Springer-Verlag, Heidelberg, Germany.
4. 4. Platt J.L. (1996) Xenotransplantation: recent progress and current perspectives. Curr Opin Immunol 8, 721.
5. 5. Marcheth P., Scharp D.W., Finke E.H. et al. (1996) Prolonged survival of discordant porcine islet xenografts. Transplantation 61, 1100.
6. 6. Mirenda V., Sigalla J., Fiche M. et al. (1997) Pig pancreatic islet xenografts in a B-cell-deficient mouse model. Transplant Proc 29, 762.
7. 7. Deng S., Buhler L., Lou J. et al. (1994) Study of concordant xenografted islets of Langerhans rejection: humoral or cellular mechanism? Transplant Proc 26, 1184.
8. 8. Schaapherder A.F., Wolvekamp M.C., Te Bulte M.T., Bouwman E., Gooszen H.G. & Daha M.R. (1996) Porcine islet cells of Langerhans are destroyed by human complement and not by antibody-dependent cell-mediated mechanisms. Transplantation 62, 29.
9. 9. Shapiro A.M., Hao E., Rajotte R.V. & Kneteman N.M. (1996) High yield of rodent islets with intraductal collagenase and stationary digestion a comparison with standard technique. Cell Transplant 5, 631.
10. 10. Mancini G., Carbonara A.O. & Heremans J.F. (1965) Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2, 235.
11. 11. Alpert E., Monroe M. & Schur P.H. (1970) A method for increasing the sensitivity of radial-immunodiffusion assay. Lancet i, 1120.
12. 12. Lou J., Ythier A., Burger D. et al. (1997) Modulation of soluble and membrane-bound TNF-induced phenotypic and functional changes of human brain microvascular endothelial cells by recombinant TNF binding protein I. J Neuroimmunol 77, 107.
13. 13. Buhler L., Deng S., Andereggen E., Bubloz C., Rohner A. & Morel P. ( 1994) Comparison of concordant and discordant xenografted islets of Langerhans rejection. Transplant Proc 26, 3453.
14. 14. Vogel C. (1992) Cobra venom factor. In: Encyclopedia of Immunology (eds I. Roitt & P. Delves), p. 363. Academic Press, London, UK.
15. 15. Leventhal J.R., Dalmasso A.P., Cromwell J.W. et al. (1993) Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 55, 857.
16. 16. Kin T., Nakajima Y., Kanehiro H. et al. (1996) Effect of complement activation in human serum on isolated porcine islets. Cell Transplant 5, 45.
17. 17. Deng S., Ketchum R.J., Levy M.M. et al. (1996) Long-term culture or complement inhibition improves early islet function in dog to rat islet xenotransplantation. Transplant Proc 28, 805.
18. 18. Karlsson-Parra A., Ridderstad A., Wallgren A.C., Moller E., Ljunggren H.G. & Korsgren O. (1996) Xenograft rejection of porcine islet-like cell clusters in normal and natural killer cell-depleted mice. Transplantation 61, 1313.
19. 19. Rabinovitch A., Sumoski W., Rajotte R.V. & Warnock G.L. (1990) Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. J Clin Endocrinol Metab 71, 152.
20. 20. Krieger N.R., Ito H. & Fathman C.G. (1997) Rat pancreatic islet and skin xenograft survival in CD4 and CD8 knockout mice. J Autoimmun 10, 309.
21. 21. Erdei A., Fust G. & Gergely J. (1991) The role of C3 in the immune response. Immunol Today 12, 332.
22. 22. Arvieux J., Yssel H. & Colomb M.G. (1988) Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones. Immunology 65, 229.
23. 23. Erdei A., Spaeth E., Alsenz J. et al. (1984) Role of C3b receptors in the enhancement of interleukin-2-dependent T-cell proliferation. Mol Immunol 21, 1215.
24. 24. Pratt J.R., Hibbs M.J., Laver A.J., Smith R.A. & Sacks S.H. (1996) Allograft immune response with sCR1 intervention. Transpl Immunol 4, 72.